These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14741063)

  • 1. Citalopram challenge in social anxiety disorder.
    Shlik J; Maron E; Tru I; Aluoja A; Vasar V
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
    Nadeem HS; Attenburrow MJ; Cowen PJ
    Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose citalopram as a 5-HT neuroendocrine probe.
    Attenburrow MJ; Mitter PR; Whale R; Terao T; Cowen PJ
    Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral racemic citalopram on neuroendocrine responses.
    Hawken ER; Owen JA; Van Vugt D; Delva NJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):694-700. PubMed ID: 16563590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State and trait abnormalities in serotonin function in major depression.
    Bhagwagar Z; Whale R; Cowen PJ
    Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.
    Henning J; Netter P
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
    Lowe SL; Yeo KP; Teng L; Soon DK; Pan A; Wise SD; Peck RW
    Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation.
    Labuschagne I; Croft RJ; Phan KL; Nathan PJ
    J Psychopharmacol; 2010 Aug; 24(8):1153-64. PubMed ID: 18832432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serotoninergic challenge with oral citalopram.
    Mattos P; Franco VA; Noel F; Segenreich D; Gonçalves JC
    Braz J Psychiatry; 2006 Sep; 28(3):203-5. PubMed ID: 17063220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.
    Seifritz E; Müller MJ; Annen O; Nil R; Hatzinger M; Hemmeter U; Moore P; Holsboer-Trachsler E
    J Psychiatr Res; 1997; 31(5):543-54. PubMed ID: 9368196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
    Kilkens TO; Honig A; Fekkes D; Brummer RJ
    Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP
    J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
    Lotrich FE; Bies R; Muldoon MF; Manuck SB; Smith GS; Pollock BG
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.
    Shlik J; Aluoja A; Vasar V; Vasar E; Podar T; Bradwejn J
    J Psychiatry Neurosci; 1997 Nov; 22(5):332-40. PubMed ID: 9401314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition.
    Ashina S; Bendtsen L; Jensen R
    Pain; 2004 Mar; 108(1-2):108-14. PubMed ID: 15109513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.
    Wong WM; Hasemann S; Schwarz M; Zill P; Koller G; Soyka M; Preuss UW
    Pharmacopsychiatry; 2008 Mar; 41(2):72-8. PubMed ID: 18311688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The citalopram challenge test in patients with major depression and in healthy controls.
    Kapitany T; Schindl M; Schindler SD; Hesselmann B; Füreder T; Barnas C; Sieghart W; Kasper S
    Psychiatry Res; 1999 Nov; 88(2):75-88. PubMed ID: 10622344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.